52 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M N/A
Article Searches
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4066331-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2017-results-earnings-call?source=feed_sector_healthcare Apr 27, 2017 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2017 Results Earnings Conference Call April 26, 2017 4:30 p.m. ET Executives Trevin Rard - IR Mike Hunkapiller - Chief Executive Officer Susan
Pacific Biosciences of California Reports Q1 Loss Due to Higher Costs https://www.fool.com/investing/2017/04/27/pacific-biosciences-of-california-reports-q1-loss.aspx?source=iedfolrf0000001 Apr 27, 2017 - The genetic-sequencing company increased revenue, but still wound up with a wider loss.
Here's Why Pacific Biosciences of California Is Sliding Today https://www.fool.com/investing/2017/04/27/heres-why-pacific-biosciences-of-california-is-sli.aspx?source=iedfolrf0000001 Apr 27, 2017 - Mixed first-quarter results near the top line led to a wider-than-expected first-quarter loss on the bottom line.
Pacific Biosciences (PACB) Q1 Loss Wider than Estimated http://www.zacks.com/stock/news/258121/pacific-biosciences-pacb-q1-loss-wider-than-estimated?cid=CS-ZC-FT-258121 Apr 27, 2017 - Pacific Biosciences of California Inc. (PACB) reported a loss of 26 cents per share in the first quarter of 2017. The figure is 3 cents wider than the Zacks Consensus Estimate.
The Top Gene-Sequencing Stock to Buy in 2017 https://www.fool.com/investing/2017/04/20/the-top-gene-sequencing-stock-to-buy-in-2017.aspx?source=iedfolrf0000001 Apr 20, 2017 - Illumina is investors' best buy in this category.
Pacific Biosciences (PACB): What Awaits in Q1 Earnings? http://www.zacks.com/stock/news/256482/pacific-biosciences-pacb-what-awaits-in-q1-earnings?cid=CS-ZC-FT-256482 Apr 17, 2017 - Pacific Biosciences of California Inc. (PACB) is scheduled to report first-quarter 2017 results on Apr 20.
3 Big Reasons to Be Bullish on Biotech Stocks https://www.fool.com/investing/2017/04/16/3-big-reasons-to-be-bullish-on-biotech-stocks.aspx?source=iedfolrf0000001 Apr 16, 2017 - Have you shied away from investing in the biotech sector? Here are three key reasons why you may want to reconsider that decision.
Pacific Biosciences (PACB) Q2 Impressive, View Encourages http://www.zacks.com/stock/news/226964/pacific-biosciences-pacb-q2-impressive-view-encourages?cid=CS-ZC-FT-226964 Aug 05, 2016 - Pacific Biosciences of California Inc. (PACB) reported a loss of 21 cents per share, a penny narrower than the Zacks Consensus Estimate.
Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3996134-pacific-biosciences-californias-pacb-ceo-mike-hunkapiller-q1-2016-results-earnings-call?source=feed_sector_healthcare Aug 05, 2016 - Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2016 Earnings Conference Call August 4, 2016 04:30 PM ET Executives Trevin Rard - IR Mike Hunkapiller - CEO Susan Barnes - CFO Ben Gong - VP, F
Pacific Biosciences (PACB) Q2 Earnings: What's in Store? http://www.zacks.com/stock/news/226033/pacific-biosciences-pacb-q2-earnings-whats-in-store?cid=CS-ZC-FT-226033 Aug 01, 2016 - Pacific Biosciences of California Inc. (PACB) is scheduled to report second-quarter 2016 results on Aug 4.

Pages: 123456

<<<Page 5